Jun. 4 at 7:44 PM
Cantor assumed
$GHRS Overweight-
$25 (prev.
$14) and Josh said, "Smoking the Toad - A Big Wave of Psychedelics Is Coming - Assuming Coverage" - "We've assumed lead coverage of
$GHRS from Charles following his retirement and are updating our investment thesis and model."
$JNJ $CYBN $MNMD $ATAI CMPS
Cantor additionally said in its
$GHRS note: "We maintain an Overweight rating and introduce a
$25 PT.
Data generated for psychedelics across a number of mental health disorders (depression, PTSD, anxiety, etc) have been transformational.
Many of these psychiatric conditions are poorly served by current treatment options, such as SSRIs or atypical antipsychotics.
The unmet need is enormous and growing.
Cantor went on to say:
